[Elsevier] Safety and efficacy of subcutaneous injection with HMI-115 versus placebo in endometriosis-associated pain in premenopausal women: a multicentre, double-blind, randomised, proof-of-concept phase 2 trial

BerbarianWizard Post time Yesterday 06:29 | Show all posts |Read mode
This post will be closed automatically in 2026-09-10 06:29
Reward10points

journalㄩThe Lancet Obstetrics, Gynaecology, & Women's Health

AuthorsㄩLan Zhu; Zi-Jiang Chen; Haiyuan Liu; Guoyun Wang; Krzysztof Dynowski; Songying Zhang; Liehong Wang; Wenyan Wang; Xiaoqin Gan; Shunyu Hou; Ruixia Guo; Xinmei Zhang; Hongjie Ruan; Hong Xu; Shuping Zhao; Yu Zhang; Chongdong Liu; Yingjun Zhu; Haiyan Liu; Boqun Xu; Sun Fang; Sheng Tu; Xinli Hu; Xi Chen; Rui-Ping Xiao

Published dateㄩ2025-11-

DOIㄩ10.1016/j.lanogw.2025.100032

PDF linkㄩhttps://www.sciencedirect.com/sc ... 050503825000329/pdf

Article linkㄩhttps://doi.org/10.1016/j.lanogw.2025.100032

Article SourceㄩElsevier BV


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
JoseParedes Post time Yesterday 06:29 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Junior Member
  • post

  • reply

  • points

    20


Return to the list